Acrospire Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-2,557
| Closed | -$42K | – | 1383 |
|
2017
Q2 | $42K | Sell |
2,557
-3,400
| -57% | -$55.8K | 0.04% | 1024 |
|
2017
Q1 | $83K | Sell |
5,957
-16,730
| -74% | -$233K | 0.07% | 458 |
|
2016
Q4 | $362K | Buy |
22,687
+12,793
| +129% | +$204K | 0.15% | 79 |
|
2016
Q3 | $165K | Buy |
9,894
+1,516
| +18% | +$25.3K | 0.11% | 232 |
|
2016
Q2 | $94K | Sell |
8,378
-3,822
| -31% | -$42.9K | 0.07% | 507 |
|
2016
Q1 | $102K | Buy |
+12,200
| New | +$102K | 0.07% | 313 |
|